Nucleic Acid Type

Clinical application

Evidence level

CTCs

Prognosis

I Metastatic Breast Cancer

II-2 Prostate carcinoma

Exosomes

Prognosis

III

Circulating Nucleic Acids

cfDNA

Prognosis

II-2

cfRNA

Therapy response

III

miRNA

Prognosis

Pre-clinical